In a comprehensive study evaluating the players of the PGE2 pathway in breast cancer patient tumors, MRP4, PGT, and 15-PGDH were noted as differentially expressed among distinct breast cancer subtypes (64). This evidence concerns the gene ABCC4 and breast cancer.